Disclosure of a diagnosis of borderline personality disorder

Journal of Psychiatric Practice
Elizabeth R Lequesne, Richard G Hersh

Abstract

Borderline personality disorder (BPD) is a common psychiatric disorder with a prevalence of 1%-2% in the general population. BPD also has the potential to cause significant distress in the lives of patients with BPD and their families. The diagnosis of BPD, however, is often withheld from patients. The purpose of this article is to explore the history of diagnostic disclosure in medicine and psychiatry and then discuss reasons why clinicians may or may not disclose the diagnosis of BPD. The authors review medical literature about diagnostic disclosure and other issues that may affect the decision to disclose a diagnosis of BPD. The authors discuss the historical precedents for diagnostic disclosure and reasons a clinician may not disclose the diagnosis of BPD to a patient: questions regarding the validity of BPD as a diagnosis, worries about the stigma of the diagnosis being harmful to the patient, and transference/countertransference issues common in the treatment of patients with BPD. The authors cite factors promoting disclosure, such as the ideal of patient autonomy, possibilities for psychoeducation and collaboration with the patient toward more specific and effective therapies, and the increasing availability of diagnosti...Continue Reading

References

Feb 1, 1992·Psychological Medicine·P McDonald-ScottH Satoh
Aug 1, 1991·The American Journal of Psychiatry·J G Gunderson, K A Phillips
Mar 1, 1989·Journal of Medical Ethics·J M Atkinson
Jun 1, 1987·Hospital & Community Psychiatry·R S Green, A B Gantt
Dec 1, 1972·The British Journal of Medical Psychology·G Adler
May 1, 1974·Archives of General Psychiatry·J T Maltsberger, D H Buie
Dec 1, 1984·The American Journal of Psychiatry·D E Reiser, H Levenson
Nov 1, 1983·The American Journal of Psychiatry·K A Henry, C I Cohen
Aug 1, 1984·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R J Goldberg
Apr 1, 1995·The American Journal of Psychiatry·M GolombJ F Rosenbaum
Dec 1, 1996·The Journal of Nervous and Mental Disease·C M GriloT H McGlashan
Dec 8, 1998·The American Journal of Psychiatry·M C ZanariniV Reynolds
Jun 16, 1999·Journal of Abnormal Psychology·M N Funtowicz, T A Widiger
Oct 13, 1999·The American Journal of Psychiatry·M Zimmerman, J I Mattia
Mar 17, 2000·BMJ : British Medical Journal·P Bracken, P Thomas
Mar 24, 2000·The Psychiatric Clinics of North America·K R Silk
Sep 7, 2000·The British Journal of Psychiatry : the Journal of Mental Science·G Pinner
Nov 22, 2000·The American Journal of Orthopsychiatry·D Becker
Dec 5, 2000·The British Journal of Psychiatry : the Journal of Mental Science·A AhujaA Ahujn
Feb 7, 2001·The American Journal of Psychiatry·D S BenderJ G Gunderson
Feb 24, 2001·Journal of Personality Disorders·M C ZanariniJ G Gunderson
Mar 13, 2001·Comprehensive Psychiatry·M C ZanariniJ Bleichmar
Jun 29, 2001·Archives of General Psychiatry·S TorgersenV Cramer
Dec 1, 2001·Psychiatric Services : a Journal of the American Psychiatric Association·B G LinkJ C Phelan
Jul 11, 2002·The American Journal of Medicine·Ami Schattner, Merav Tal
Dec 11, 2002·Kennedy Institute of Ethics Journal·Mark ParascandolaMarion Danis

❮ Previous
Next ❯

Citations

Jan 7, 2006·Epidemiologia e psichiatria sociale·Monica PaccaloniChrista Zimmermann
Sep 19, 2012·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Robert S Biskin, Joel Paris
Dec 21, 2013·The British Journal of Psychiatry : the Journal of Mental Science·Amy C BilderbeckGuy M Goodwin
Apr 28, 2007·International Review of Psychiatry·Graham ThornicroftAliya Kassam
Sep 16, 2014·Journal of Mental Health·Alyssa C Milton, Barbara A Mullan
May 19, 2017·Early Intervention in Psychiatry·Shona M FranceyAndrew M Chanen
Sep 20, 2011·Journal of Psychiatric Practice·Kenneth R Silk
May 21, 2010·Journal of Psychiatric Practice·David Kealy, John S Ogrodniczuk
Feb 16, 2005·Expert Opinion on Pharmacotherapy·Antonio Tursi
Jul 14, 2010·International Journal of Mental Health Nursing·Joanna Davison, Annette Huntington
Dec 31, 2005·Journal of Traumatic Stress·Rebekah BradleyDrew Westen
Feb 20, 2020·Personality and Mental Health·R LesterUNKNOWN North West Boroughs Healthcare, NHS Foundation Trust

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Psychogeriatrics
Gill Pinner, Walter Pierre Bouman
JAMA : the Journal of the American Medical Association
Sumant R RanjiKaveh G Shojania
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
Stefan KommossFriedrich Kommoss
© 2021 Meta ULC. All rights reserved